Atlas Trials

3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol

Clinical trial NCT05458622 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05458622
Sponsor
University Hospital, Brest
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Systemic Lupus Erythematosus (SLE)
Start date
2022-11-29
Primary completion
2026-11-01
Enrollment
25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.